Hunter Fleming Company Profile

16:30 EST 21st November 2017 | BioPortfolio

Hunter-Fleming is a pharmaceutical development company which specializes in bridging the product development gap between world-wide academic research and pharmaceutical marketing companies


Regus House, 1 Friary Temple Quay
United Kingdom


Phone: +44 (0) 117 900 8265
Fax: +44 (0) 117 900 8492

News Articles [78 Associated News Articles listed on BioPortfolio]

US FDA bans APIs made by Fleming Labs

Fleming Laboratories has been banned from shipping APIs to the US by the FDA which says its manufacturing plant in Nawabpet, Telangana in India is not up to code.

Neolithic farmers coexisted with hunter-gatherers for centuries in Europe

(Max Planck Institute for the Science of Human History) New research answers a long-debated question among anthropologists, archaeologists and geneticists: when farmers first arrived in Europe, how di...

Hunter Accidentally Shoots Therapy Dog In Front Of Owner

The owner wrote in a Facebook post the hunter shot Kaoru because "he thought she was a wolf surrounded by seven other dogs and 10 feet away from my teammate and me."

The Infection Preventionist's Role in Antimicrobial Stewardship Programs

By Luci Perri, RN, MSN, MPH, CIC, FAPIC During his Nobel Prize acceptance speech, Alexander Fleming spoke of the potential organisms to develop resistance to penicillin due to overuse and under dosing...

Renée Fleming Named Artist Spokesperson for AMTA & Music Therapy

WASHINGTON, Sept. 18, 2017 /PRNewswire-USNewswire/ -- The American Music Therapy Association (AMTA) is honored to welcome renowned soprano, Renée Fleming, as our newest artist spokesperson. &nbs...

Gold Star Widow: 'I Just Want These Men to Be Remembered

Gold Star widow Whitney Hunter, whose husband, Sgt. Jonathon Hunter, was killed in Afghanistan in August, tells MSNBC’s Stephanie Ruhle that she was told she would receive a call from the President,...

Hunter-gatherers' seasonal gut-microbe diversity loss echoes our permanent one

More evidence that our intestinal microbes are profoundly influenced by the foods we eat—or don't: The gut ecosystems of members of a small group of hunter-gatherers inhabiting Tanzania's Rift Valle...

QuintilesIMS’ Jim Hunter wins Pratt Award

The National Association of Chain Drug Stores bestowed its Harold W. Pratt Award to Jim Hunter, VP of supplier services at QuintilesIMS, during the Business Program at  NACDS Total Store Expo in ...

Drugs and Medications [63 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Fleming County Hospital Home Medical Equipment]


Nephrocaps [Fleming & Company, Pharmaceuticals]


Nephrocaps-qt [Fleming & Company, Pharmaceuticals]


Scent-a-way anti-perspirant [Hunter's Specialties]

Scent-A-Way Extended Protection Anti-Perspirant

Nephrocaps [American Health Packaging]


PubMed Articles [29 Associated PubMed Articles listed on BioPortfolio]

Multimodal image analysis of the retina in Hunter syndrome (mucopolysaccharidosis type II): Case report.

We report a case of retinal and posterior ocular findings in a 33-year-old man diagnosed with Hunter syndrome (Mucopolysaccharidosis type II) in a multimodal imaging way.

Bow Hunter syndrome elicited by vertebral arterial occlusion after total arch replacement.

An 83-year-old man with arch aneurysm underwent total arch replacement with frozen elephant trunk and extra-anatomical left subclavian artery bypass. One year later, he felt dizziness associated with ...

Reconstructing Prehistoric African Population Structure.

We assembled genome-wide data from 16 prehistoric Africans. We show that the anciently divergent lineage that comprises the primary ancestry of the southern African San had a wider distribution in the...

Dietary resilience among hunter-gatherers of Tierra del Fuego: Isotopic evidence in a diachronic perspective.

The native groups of Patagonia have relied on a hunter-gatherer economy well after the first Europeans and North Americans reached this part of the world. The large exploitation of marine mammals (i.e...

Survival in idursulfase-treated and untreated patients with mucopolysaccharidosis type II: data from the Hunter Outcome Survey (HOS).

Mucopolysaccharidosis type II (MPS II; Hunter syndrome; OMIM 309900) is a life-limiting, multisystemic disease with varying presentation and severity. Enzyme replacement therapy with intravenous idurs...

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

Study HGT-HIT-094 is a multicenter study designed to determine the effect on clinical parameters of neurodevelopmental status of monthly IT administration of idursulfase-IT 10 mg for 12 mo...

Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

This long-term study will provide Elaprase treatment to children enrolled in this study and will utilize data from both enrolled patients and Hunter Outcome Survey (HOS) patient registry d...

An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients

The objective of this study is to evaluate the effect of anti-idursulfase IgG, IgM & IgE antibodies on idursulfase safety (measured by infusion related adverse events) between patients who...

Pilot Prospective Study of Two Methods of Revascularization of the Femoral Artery (SFA): Stenting in the SFA, and Stenting of the SFA, Supplemented by Fasciotomy in Hunter Channel.

Comparison of two methods for revascularization of the superficial femoral artery: stenting of the superficial femoral artery vs. stenting of the superficial femoral artery supplemented wi...

Study of Idursulfase-beta (GC1111) in Hunter Syndrome

This study evaluates the efficacy and safety of three doses of GC1111 in patients with Hunter Syndrome. Participants will be randomized to one of three doses of GC1111 or comparator.

Companies [24 Associated Companies listed on BioPortfolio]

Hunter-Fleming Ltd

Hunter-Fleming is an innovative pharmaceutical development company, specializing in the development of radically novel therapeutics relevant to the treatment of acute and chronic inflammatory degenera...

Hunter Fleming

Hunter-Fleming is a pharmaceutical development company which specializes in bridging the product development gap between world-wide academic research and pharmaceutical marketing companies

Hunter Medical Inc.

Hunter Medical, Inc. was founded in 2013 by Lee Hunter M.D., M.B.A., a board-certified orthopaedic surgeon who specializes in surgery of the upper extremity, particularly the elbo...

Global Hunter Securities

Global Hunter Securities, LLC is a full service investment bank focusing on middle market corporate and institutional clients around the world. The firm provides insightful resear...

Hunter Wise Financial Group, LLC

Hunter Wise Financial Group, LLC is a specialized investment bank providing the highest quality level of corporate financing, merger, acquisition, divestiture and advisory services. The Company's clie...

More Information about "Hunter Fleming" on BioPortfolio

We have published hundreds of Hunter Fleming news stories on BioPortfolio along with dozens of Hunter Fleming Clinical Trials and PubMed Articles about Hunter Fleming for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hunter Fleming Companies in our database. You can also find out about relevant Hunter Fleming Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record